About Osmotica Pharmaceuticals Plc

Osmotica Pharmaceuticals Plc operates as a biopharmaceutical company, which engages in the development and commercialization of specialty products for neurology and women's health. Its products include M-72, Lorzone, ConZip, OB Complete, and Divigel. The company was founded in 1986 and is headquartered in Bridgewater, NJ.

At the moment the company generates 246M USD in revenues.

On its last earning announcement, the company reported a loss of -6.73$ per share.

The book value per share is 2.73$

Osmotica Pharmaceuticals Plc website


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
246M 50.50% -14M -5.60% -351M -6.73 - - 52M 2.73 63M -4M 59M